Cargando…

Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function

BACKGROUND: We sought to determine (1) long‐term outcomes in patients presenting with documented Takotsubo syndrome (TS), (2) whether left ventricular global longitudinal strain (LV‐GLS) provides incremental prognostic value, and (3) prognostic cutoffs of LV ejection fraction (LVEF) and LV‐GLS durin...

Descripción completa

Detalles Bibliográficos
Autores principales: Alashi, Alaa, Isaza, Nicolas, Faulx, Jackson, Popovic, Zoran B., Menon, Venu, Ellis, Stephen G., Faulx, Michael, Kapadia, Samir R., Griffin, Brian P., Desai, Milind Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660826/
https://www.ncbi.nlm.nih.gov/pubmed/32755253
http://dx.doi.org/10.1161/JAHA.120.016537
_version_ 1783609090838102016
author Alashi, Alaa
Isaza, Nicolas
Faulx, Jackson
Popovic, Zoran B.
Menon, Venu
Ellis, Stephen G.
Faulx, Michael
Kapadia, Samir R.
Griffin, Brian P.
Desai, Milind Y.
author_facet Alashi, Alaa
Isaza, Nicolas
Faulx, Jackson
Popovic, Zoran B.
Menon, Venu
Ellis, Stephen G.
Faulx, Michael
Kapadia, Samir R.
Griffin, Brian P.
Desai, Milind Y.
author_sort Alashi, Alaa
collection PubMed
description BACKGROUND: We sought to determine (1) long‐term outcomes in patients presenting with documented Takotsubo syndrome (TS), (2) whether left ventricular global longitudinal strain (LV‐GLS) provides incremental prognostic value, and (3) prognostic cutoffs of LV ejection fraction (LVEF) and LV‐GLS during an acute TS episode. METHODS AND RESULTS: We studied 650 patients with TS (aged 66±14 years, 88% women) who were diagnosed clinically and angiographically between 2006 and 2018. Baseline LVEF and LV‐GLS (using velocity vector imaging) were recorded. The primary end point was all‐cause mortality. TS triggers were unknown (34%), emotional (16%), physical (41%), and neurologic (10%). Mean LVEF and LV‐GLS were 36±10% and −11.6±0.4%; in addition, 94% patients had LVEF <52%, and 80% had apical ballooning. No patient had obstructive coronary artery disease. At a median of 2.2 years (interquartile range, 0.7–4.4), 175 (27%) had died (9% in‐hospital deaths). Multivariate Cox survival analysis revealed that higher age (hazard ratio [HR], 1.35), male sex (HR, 1.75), lower baseline LVEF (HR, 1.02), worse LV‐GLS (HR, 1.04), neurologic trigger (HR, 2.66), and physical trigger (HR, 2.64) were associated with mortality, whereas aspirin (HR, 0.70) and β‐blockers (HR, 0.73) improved survival (all P<0.049). The addition of LVEF and LV‐GLS to clinical markers (age, sex, cardiogenic shock at presentation, and peak troponin I) significantly increased log‐likelihood ratios: clinical (−521.48), clinical plus LVEF (−511.32, P<0.001), and clinical plus LVEF and LV‐GLS (−500.68, P<0.001). On penalized spline analysis, LVEF of 38% and LV‐GLS of −10% were cutoffs below which survival was significantly worse. CONCLUSIONS: Patients with TS with a neurologic or physical trigger had significantly worse survival than those without such a trigger, with baseline LVEF and LV‐GLS providing incremental prognostic value.
format Online
Article
Text
id pubmed-7660826
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76608262020-11-17 Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function Alashi, Alaa Isaza, Nicolas Faulx, Jackson Popovic, Zoran B. Menon, Venu Ellis, Stephen G. Faulx, Michael Kapadia, Samir R. Griffin, Brian P. Desai, Milind Y. J Am Heart Assoc Original Research BACKGROUND: We sought to determine (1) long‐term outcomes in patients presenting with documented Takotsubo syndrome (TS), (2) whether left ventricular global longitudinal strain (LV‐GLS) provides incremental prognostic value, and (3) prognostic cutoffs of LV ejection fraction (LVEF) and LV‐GLS during an acute TS episode. METHODS AND RESULTS: We studied 650 patients with TS (aged 66±14 years, 88% women) who were diagnosed clinically and angiographically between 2006 and 2018. Baseline LVEF and LV‐GLS (using velocity vector imaging) were recorded. The primary end point was all‐cause mortality. TS triggers were unknown (34%), emotional (16%), physical (41%), and neurologic (10%). Mean LVEF and LV‐GLS were 36±10% and −11.6±0.4%; in addition, 94% patients had LVEF <52%, and 80% had apical ballooning. No patient had obstructive coronary artery disease. At a median of 2.2 years (interquartile range, 0.7–4.4), 175 (27%) had died (9% in‐hospital deaths). Multivariate Cox survival analysis revealed that higher age (hazard ratio [HR], 1.35), male sex (HR, 1.75), lower baseline LVEF (HR, 1.02), worse LV‐GLS (HR, 1.04), neurologic trigger (HR, 2.66), and physical trigger (HR, 2.64) were associated with mortality, whereas aspirin (HR, 0.70) and β‐blockers (HR, 0.73) improved survival (all P<0.049). The addition of LVEF and LV‐GLS to clinical markers (age, sex, cardiogenic shock at presentation, and peak troponin I) significantly increased log‐likelihood ratios: clinical (−521.48), clinical plus LVEF (−511.32, P<0.001), and clinical plus LVEF and LV‐GLS (−500.68, P<0.001). On penalized spline analysis, LVEF of 38% and LV‐GLS of −10% were cutoffs below which survival was significantly worse. CONCLUSIONS: Patients with TS with a neurologic or physical trigger had significantly worse survival than those without such a trigger, with baseline LVEF and LV‐GLS providing incremental prognostic value. John Wiley and Sons Inc. 2020-08-05 /pmc/articles/PMC7660826/ /pubmed/32755253 http://dx.doi.org/10.1161/JAHA.120.016537 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Alashi, Alaa
Isaza, Nicolas
Faulx, Jackson
Popovic, Zoran B.
Menon, Venu
Ellis, Stephen G.
Faulx, Michael
Kapadia, Samir R.
Griffin, Brian P.
Desai, Milind Y.
Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function
title Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function
title_full Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function
title_fullStr Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function
title_full_unstemmed Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function
title_short Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function
title_sort characteristics and outcomes of patients with takotsubo syndrome: incremental prognostic value of baseline left ventricular systolic function
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660826/
https://www.ncbi.nlm.nih.gov/pubmed/32755253
http://dx.doi.org/10.1161/JAHA.120.016537
work_keys_str_mv AT alashialaa characteristicsandoutcomesofpatientswithtakotsubosyndromeincrementalprognosticvalueofbaselineleftventricularsystolicfunction
AT isazanicolas characteristicsandoutcomesofpatientswithtakotsubosyndromeincrementalprognosticvalueofbaselineleftventricularsystolicfunction
AT faulxjackson characteristicsandoutcomesofpatientswithtakotsubosyndromeincrementalprognosticvalueofbaselineleftventricularsystolicfunction
AT popoviczoranb characteristicsandoutcomesofpatientswithtakotsubosyndromeincrementalprognosticvalueofbaselineleftventricularsystolicfunction
AT menonvenu characteristicsandoutcomesofpatientswithtakotsubosyndromeincrementalprognosticvalueofbaselineleftventricularsystolicfunction
AT ellisstepheng characteristicsandoutcomesofpatientswithtakotsubosyndromeincrementalprognosticvalueofbaselineleftventricularsystolicfunction
AT faulxmichael characteristicsandoutcomesofpatientswithtakotsubosyndromeincrementalprognosticvalueofbaselineleftventricularsystolicfunction
AT kapadiasamirr characteristicsandoutcomesofpatientswithtakotsubosyndromeincrementalprognosticvalueofbaselineleftventricularsystolicfunction
AT griffinbrianp characteristicsandoutcomesofpatientswithtakotsubosyndromeincrementalprognosticvalueofbaselineleftventricularsystolicfunction
AT desaimilindy characteristicsandoutcomesofpatientswithtakotsubosyndromeincrementalprognosticvalueofbaselineleftventricularsystolicfunction